Michael W. Shannon

2.8k total citations
42 papers, 1.8k citations indexed

About

Michael W. Shannon is a scholar working on Emergency Medicine, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Michael W. Shannon has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Emergency Medicine, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Pharmacology. Recurrent topics in Michael W. Shannon's work include Poisoning and overdose treatments (13 papers), Emergency and Acute Care Studies (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Michael W. Shannon is often cited by papers focused on Poisoning and overdose treatments (13 papers), Emergency and Acute Care Studies (5 papers) and Forensic Toxicology and Drug Analysis (4 papers). Michael W. Shannon collaborates with scholars based in United States, Tunisia and Canada. Michael W. Shannon's co-authors include Florence T. Bourgeois, Kenneth D. Mandl, Clarissa Valim, Holly Perry, Alan D. Woolf, Steven D. Salhanick, Robert O. Wright, Catherine James, Gary Fleisher and Anne M. Stack and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Annals of the New York Academy of Sciences.

In The Last Decade

Michael W. Shannon

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Shannon United States 21 718 319 225 221 216 42 1.8k
Daniel J. Cobaugh United States 25 1.1k 1.6× 238 0.7× 239 1.1× 178 0.8× 125 0.6× 54 2.2k
David Reith New Zealand 25 362 0.5× 549 1.7× 255 1.1× 129 0.6× 195 0.9× 124 2.0k
Maryann Mazer‐Amirshahi United States 24 371 0.5× 306 1.0× 170 0.8× 118 0.5× 128 0.6× 133 1.8k
Peter J. Zed Canada 29 407 0.6× 462 1.4× 116 0.5× 173 0.8× 368 1.7× 108 2.5k
Marc Afilalo Canada 25 971 1.4× 184 0.6× 149 0.7× 298 1.3× 291 1.3× 80 2.6k
Andrew I. Geller United States 19 289 0.4× 176 0.6× 157 0.7× 111 0.5× 145 0.7× 46 2.3k
Gary M. Oderda United States 32 511 0.7× 337 1.1× 355 1.6× 201 0.9× 1.4k 6.3× 131 3.4k
Bryan D. Hayes United States 22 507 0.7× 214 0.7× 242 1.1× 97 0.4× 237 1.1× 84 1.8k
Jody L. Green United States 22 1.2k 1.6× 624 2.0× 375 1.7× 301 1.4× 311 1.4× 75 3.4k
Karl A. Sporer United States 26 1.2k 1.7× 285 0.9× 271 1.2× 149 0.7× 181 0.8× 78 2.5k

Countries citing papers authored by Michael W. Shannon

Since Specialization
Citations

This map shows the geographic impact of Michael W. Shannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Shannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Shannon more than expected).

Fields of papers citing papers by Michael W. Shannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Shannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Shannon. The network helps show where Michael W. Shannon may publish in the future.

Co-authorship network of co-authors of Michael W. Shannon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Shannon. A scholar is included among the top collaborators of Michael W. Shannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Shannon. Michael W. Shannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Bournissen, Facundo, et al.. (2010). Predisposition to epilepsy—Does the ABCB1 gene play a role?. Epilepsia. 51(9). 1882–1885. 27 indexed citations
2.
Bourgeois, Florence T., Kenneth D. Mandl, Clarissa Valim, & Michael W. Shannon. (2009). Pediatric Adverse Drug Events in the Outpatient Setting: An 11-Year National Analysis. PEDIATRICS. 124(4). e744–e750. 72 indexed citations
3.
Parry, Gareth, et al.. (2009). The Effect of Hospital Bed Occupancy on Throughput in the Pediatric Emergency Department. Annals of Emergency Medicine. 53(6). 767–776.e3. 66 indexed citations
4.
Kimia, Amir A., Mark L. Waltzman, Michael W. Shannon, et al.. (2009). Glass Table-Related Injuries in Children. Pediatric Emergency Care. 25(3). 145–149. 8 indexed citations
5.
Bourgeois, Florence T., Michael W. Shannon, & Anne M. Stack. (2008). “Left Without Being Seen”: A National Profile of Children Who Leave the Emergency Department Before Evaluation. Annals of Emergency Medicine. 52(6). 599–605. 47 indexed citations
6.
George, Mathew, et al.. (2008). Obtundation and seizure following ondansetron overdose in an infant. Clinical Toxicology. 46(10). 1064–1066. 14 indexed citations
7.
Murphy, Carol, Jonathan N. Glickman, Kinga K. Tomczak, et al.. (2008). Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression. Mucosal Immunology. 1(4). 297–308. 37 indexed citations
8.
Bourgeois, Florence T. & Michael W. Shannon. (2007). Emergency Care for Children in Pediatric and General Emergency Departments. Pediatric Emergency Care. 23(2). 94–102. 127 indexed citations
9.
Shannon, Michael W., et al.. (2006). Pralidoxime Safety andToxicity In Children. Prehospital Emergency Care. 11(1). 36–41. 2 indexed citations
10.
Roberts, James R., William B. Weil, & Michael W. Shannon. (2005). DEET alternatives considered to be effective mosquito repellents. AAP News. 26(6). 15–16. 2 indexed citations
11.
Shannon, Michael W., et al.. (2004). 4‐Methylpyrazole Decreases 1,4‐Butanediol Toxicity by Blocking Its in Vivo Biotransformation to γ‐Hydroxybutyric Acid. Annals of the New York Academy of Sciences. 1025(1). 528–537. 8 indexed citations
12.
Shannon, Michael W., et al.. (2003). Case 30-2003. New England Journal of Medicine. 349(13). 1267–1275. 14 indexed citations
13.
Kraner, James C., et al.. (2002). Enzyme and Receptor Antagonists for Preventing Toxicity from the Gamma‐Hydroxybutyric Acid Precursor 1,4‐Butanediol in CD‐1 Mice. Annals of the New York Academy of Sciences. 965(1). 461–472. 23 indexed citations
14.
Kaplan, Ron L., et al.. (2001). Nalmefene for elective reversal of procedural sedation in children. The American Journal of Emergency Medicine. 19(7). 545–548. 9 indexed citations
15.
Burns, Michele M., et al.. (2000). False-Positive Tricyclic Antidepressant Drug Screen Results Leading to the Diagnosis of Carbamazepine Intoxication. PEDIATRICS. 105(5). e66–e66. 22 indexed citations
16.
Perry, Holly & Michael W. Shannon. (1998). Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: Results of an open-label, clinical trial. The Journal of Pediatrics. 132(1). 149–152. 68 indexed citations
17.
Wright, Robert O., Alan D. Woolf, Michael W. Shannon, & B Magnani. (1998). N‐Acetylcysteine Reduces Methemoglobin in an In‐vitro Model of Glucose‐6‐phosphate Dehydrogenase Deficiency. Academic Emergency Medicine. 5(3). 225–229. 15 indexed citations
18.
Perry, Holly & Michael W. Shannon. (1996). Diagnosis and management of opioid- and benzodiazepine-induced comatose overdose in children. Current Opinion in Pediatrics. 8(3). 243–247. 15 indexed citations
19.
Shannon, Michael W., et al.. (1996). Intravenous magnesium therapy for moderate to severe pediatric asthma: Results of a randomized, placebo-controlled trial. The Journal of Pediatrics. 129(6). 809–814. 130 indexed citations
20.
Shannon, Michael W.. (1992). Duration of QRS Disturbances After Severe Tricyclic Antidepressant Intoxication. Journal of Toxicology Clinical Toxicology. 30(3). 377–386. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Cobaugh Breakdown of academic impact, for papers by David Reith Breakdown of academic impact, for papers by Maryann Mazer‐Amirshahi Breakdown of academic impact, for papers by Peter J. Zed Breakdown of academic impact, for papers by Marc Afilalo Breakdown of academic impact, for papers by Andrew I. Geller Breakdown of academic impact, for papers by Gary M. Oderda Breakdown of academic impact, for papers by Bryan D. Hayes Breakdown of academic impact, for papers by Jody L. Green Breakdown of academic impact, for papers by Karl A. Sporer
Rankless by CCL
2026